Developments within Biobanking
Contributor: Pharma IQ
Posted: 07/20/2010 12:00:00 AM EDT | 0
Posted: 07/20/2010 12:00:00 AM EDT | 0
|
|
The challenges faced by the pharmaceutical industry in terms of discovering and utilising the full potential of biobanking are multifaceted. Much has been made of the ethical questions raised by the storage of biological samples and data, however beyond this are the practical and logistical challenges it poses. For the pharmaceutical industry, improved biobanking facilities means enhanced...
To Continue Reading This Article, Please Sign in or Sign up
To Continue Reading This Article, Please Sign in or Sign up
-
Global Pharmaceutical Contract Manufacturing Soars -
From Supply Chain to Value Chain: The Leadership Challenge -
Paediatric Investigation Plans: Burden or boost? -
India Looks to a Future in Clinical Trials -
Saving Time by Meeting CDISC Standards -
Making Inroads in the Contract Manufacturing Sector -
Targeting New Markets to Improve Pharma Sales Force Effectiveness -
UK Leads European Biobank Progress -
High Throughput Screening Lessons Learnt: How Biobanking Can Benefit? -
Effectively Choosing a CRO that Best Suits Your Needs
* = required.
Not a member yet? Sign up
You Should Check Out:
Advertisement
Events of Interest
-
Pharma Logistics & Cold Chain
Novotel Morumbi, São Paulo, SP
October 19- 20, 2010 -
ELNs: Advanced Laboratory Solutions
Marriott Hotel, Amsterdam, The Netherlands
September 27- 29, 2010 -
11th Contract Manufacturing for Pharmaceuticals and Biotech
Venue to be confirmed, Philadelphia
December 6- 8, 2010 -
Operational Excellence in Pharmaceuticals, Biotech and Medical Devices 2010
CCT Canary Wharf, London, UK
December 6- 8, 2010
You Might Also Like
-
Top 3 Tips for Assessing when to Partner with an External Sample Resource
Dr. Aleks Davis Biobanking Process Manager at Eli Lilly joins Pharma IQ to discuss challenges for
Pharma IQ
-
UK Leads European Biobank Progress
The UK Biobank has smashed its initial target of filing the DNA of 500,000 adults aged 40-69, in what is...Read more
Pharma IQ
-
High Throughput Screening Lessons Learnt: How Biobanking Can Benefit?
Mark Divers is the head of the Karolinska Institute’s biobank project in Sweden. He talks us through...Read more
Pharma IQ
-
Converting Problems into Opportunities When Building Up a Biobank
Pharma IQ is joined by Mark Divers, Executive Director, KI Biobank at Karolinska Institute, to discuss
Pharma IQ
|
Reach Pharma professionals through cost-effective marketing opportunities to deliver your message, position yourself as a thought leader, and introduce new products, techniques and strategies to the market.
Learn More >> Join today and interact with a vibrant network of pharma professionals, keeping up to date with the pharma industry by accessing our wealth of Pharma articles, videos, online seminars, live conferences and more. Sign Up Today! |
| Pharma IQ, a division of IQPC 2010 All rights reserved.Use of this site constitutes acceptance of our User Agreement and Privacy Policy. Careers With IQPC | Contact Us | Unsubscribe to Bizo |
|